D0612 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from D0612. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In D0612 Today - Breaking & Trending Today
ND0612, a continuous 24 hours/day subcutaneous (SC) infusion?of liquid levodopa/carbidopa (LD/CD), showed superior efficacy compared to oral LD/CD for the primary endpoint ("ON" time without ....